Craig Hettenbach
Stock Analyst at Morgan Stanley
(2.70)
# 1,901
Out of 5,146 analysts
307
Total ratings
58.04%
Success rate
-0.66%
Average return
Main Sectors:
Stocks Rated by Craig Hettenbach
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HIMS Hims & Hers Health | Maintains: Equal-Weight | $40 → $21 | $14.82 | +41.70% | 5 | Feb 25, 2026 | |
| VEEV Veeva Systems | Upgrades: Equal-Weight | $222 → $205 | $182.78 | +12.16% | 10 | Feb 17, 2026 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $5 → $4 | $1.85 | +116.80% | 3 | Dec 18, 2025 | |
| AMWL American Well | Maintains: Equal-Weight | $11 → $6 | $5.60 | +7.14% | 6 | Dec 18, 2025 | |
| HCA HCA Healthcare | Downgrades: Underweight | $425 | $530.40 | -19.87% | 5 | Dec 15, 2025 | |
| ARDT Ardent Health | Downgrades: Equal-Weight | $22 → $12 | $9.45 | +26.98% | 3 | Nov 14, 2025 | |
| HNGE Hinge Health | Maintains: Overweight | $57 → $67 | $42.71 | +56.87% | 3 | Sep 23, 2025 | |
| SLAB Silicon Laboratories | Maintains: Equal-Weight | $157 → $144 | $204.80 | -29.69% | 15 | Aug 6, 2025 | |
| OMDA Omada Health | Initiates: Overweight | $25 | $12.24 | +104.25% | 1 | Jul 1, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $175 → $210 | $236.00 | -11.02% | 3 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $200 | $207.45 | -3.59% | 1 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $9 → $5 | $1.24 | +303.23% | 12 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $96 → $114 | $58.62 | +94.47% | 24 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $57 | $37.15 | +53.43% | 19 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $81 | $73.47 | +10.25% | 23 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $35 | $24.43 | +43.27% | 4 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $13.52 | +33.19% | 4 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $185 | $81.68 | +126.49% | 23 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $162 → $167 | $230.16 | -27.44% | 23 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $42 | $144.15 | -70.86% | 25 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $159 | $211.79 | -24.93% | 2 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $125 | $79.51 | +57.21% | 3 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $72 | $317.73 | -77.24% | 22 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $193 → $195 | $209.31 | -6.84% | 3 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $488 | $291.71 | +67.29% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $297 → $296 | $150.53 | +96.64% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $273 → $368 | $287.65 | +27.93% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $513 | $189.22 | +171.11% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $275 | $288.89 | -4.81% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $88 | $44.17 | +99.23% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | n/a | $65.86 | - | 11 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $185 | $80.45 | +129.96% | 2 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $190 → $213 | $225.25 | -5.44% | 19 | Apr 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $53 → $58 | $120.37 | -51.82% | 12 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $101 → $117 | $350.39 | -66.61% | 15 | Jun 16, 2020 |
Hims & Hers Health
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $40 → $21
Current: $14.82
Upside: +41.70%
Veeva Systems
Feb 17, 2026
Upgrades: Equal-Weight
Price Target: $222 → $205
Current: $182.78
Upside: +12.16%
GoodRx Holdings
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $5 → $4
Current: $1.85
Upside: +116.80%
American Well
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $11 → $6
Current: $5.60
Upside: +7.14%
HCA Healthcare
Dec 15, 2025
Downgrades: Underweight
Price Target: $425
Current: $530.40
Upside: -19.87%
Ardent Health
Nov 14, 2025
Downgrades: Equal-Weight
Price Target: $22 → $12
Current: $9.45
Upside: +26.98%
Hinge Health
Sep 23, 2025
Maintains: Overweight
Price Target: $57 → $67
Current: $42.71
Upside: +56.87%
Silicon Laboratories
Aug 6, 2025
Maintains: Equal-Weight
Price Target: $157 → $144
Current: $204.80
Upside: -29.69%
Omada Health
Jul 1, 2025
Initiates: Overweight
Price Target: $25
Current: $12.24
Upside: +104.25%
Tenet Healthcare
Jun 9, 2025
Maintains: Overweight
Price Target: $175 → $210
Current: $236.00
Upside: -11.02%
Mar 26, 2025
Initiates: Equal-Weight
Price Target: $200
Current: $207.45
Upside: -3.59%
Aug 6, 2024
Maintains: Equal-Weight
Price Target: $9 → $5
Current: $1.24
Upside: +303.23%
Feb 7, 2023
Maintains: Equal-Weight
Price Target: $96 → $114
Current: $58.62
Upside: +94.47%
Jun 10, 2022
Maintains: Overweight
Price Target: $62 → $57
Current: $37.15
Upside: +53.43%
Jun 10, 2022
Maintains: Overweight
Price Target: $85 → $81
Current: $73.47
Upside: +10.25%
May 18, 2022
Maintains: Equal-Weight
Price Target: $55 → $35
Current: $24.43
Upside: +43.27%
Mar 28, 2022
Maintains: Overweight
Price Target: $20 → $18
Current: $13.52
Upside: +33.19%
Feb 3, 2022
Maintains: Overweight
Price Target: $208 → $185
Current: $81.68
Upside: +126.49%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $162 → $167
Current: $230.16
Upside: -27.44%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $42 → $42
Current: $144.15
Upside: -70.86%
Dec 17, 2021
Maintains: Equal-Weight
Price Target: $165 → $159
Current: $211.79
Upside: -24.93%
Dec 13, 2021
Maintains: Overweight
Price Target: $115 → $125
Current: $79.51
Upside: +57.21%
Dec 10, 2021
Maintains: Overweight
Price Target: $57 → $72
Current: $317.73
Upside: -77.24%
Oct 27, 2021
Maintains: Underweight
Price Target: $193 → $195
Current: $209.31
Upside: -6.84%
Aug 31, 2021
Maintains: Overweight
Price Target: $515 → $488
Current: $291.71
Upside: +67.29%
Aug 31, 2021
Maintains: Overweight
Price Target: $297 → $296
Current: $150.53
Upside: +96.64%
Aug 31, 2021
Maintains: Overweight
Price Target: $273 → $368
Current: $287.65
Upside: +27.93%
Aug 31, 2021
Maintains: Overweight
Price Target: $500 → $513
Current: $189.22
Upside: +171.11%
Aug 31, 2021
Maintains: Overweight
Price Target: $321 → $275
Current: $288.89
Upside: -4.81%
Aug 31, 2021
Maintains: Overweight
Price Target: $94 → $88
Current: $44.17
Upside: +99.23%
Aug 3, 2021
Upgrades: Equal-Weight
Price Target: n/a
Current: $65.86
Upside: -
May 7, 2021
Maintains: Overweight
Price Target: $173 → $185
Current: $80.45
Upside: +129.96%
Apr 8, 2021
Downgrades: Equal-Weight
Price Target: $190 → $213
Current: $225.25
Upside: -5.44%
Feb 11, 2021
Maintains: Equal-Weight
Price Target: $53 → $58
Current: $120.37
Upside: -51.82%
Jun 16, 2020
Maintains: Equal-Weight
Price Target: $101 → $117
Current: $350.39
Upside: -66.61%